News In Brief
This article was originally published in The Gray Sheet
Bard buys Medivance
You may also be interested in...
Bard’s Summer Pipeline Includes Cooling Arctic Blast Products
Executives recently described a series of upcoming product rollouts, including a new temperature management device.
New Products In Brief
Recent approvals and launches include St. Jude Medical’s EnligHTN renal denervation system for hypertension and Zeltiq Aesthetics’ expanded CoolSculpting clearance for fat reduction.
Bard Buys Lutonix For Lead In Race To U.S. Market With Drug-Coated Balloon
Deal worth up to $325 million makes Bard first in line to enter the U.S. market with a drug-coated balloon. Firm anticipates PMA submission for Moxy in 2014.